Google DeepMind launched AlphaGenome, an AI tool designed to identify genetic drivers of disease.
The system analyses up to one million DNA letters at once and predicts how mutations affect gene regulation.
Researchers say many inherited diseases and cancers stem from regulatory mutations rather than protein-coding genes.
AlphaGenome learned from large human and mouse genetics databases.
Scientists believe it can pinpoint harmful mutations and guide new drug and gene therapy development.
Experts from University of British Columbia, University College London, and University of Exeter called the tool a major advance in understanding the genome.
Google DeepMind Unveils AlphaGenome to Decode Genetic Causes of Disease
Andrew Rogers
Andrew Rogers is a freelance journalist based in the USA, with over 10 years of experience covering Politics, World Affairs, Business, Health, Technology, Finance, Lifestyle, and Culture. He earned his degree in Journalism from the University of Florida. Throughout his career, he has contributed to outlets such as The New York Times, CNN, and Reuters. Known for his clear reporting and in-depth analysis, Andrew delivers accurate and timely news that keeps readers informed on both national and international developments.
Add A Comment